查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1807691

腫瘤分子診斷藥的全球市場:市場規模·佔有率·趨勢，產業分析 (各產品·各類型·各技術·各地區)，2025～2034年的市場預測

Oncology Based Molecular Diagnostics Market Size, Share, Trends, Industry Analysis Report By Product (Instruments, Reagents, Others), By Type, By Technology, By Region - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 129 Pages | 商品交期: 最快1-2個工作天內

價格

根據 Polaris Market Research 的一項新研究，預計到 2034 年，腫瘤分子診斷市場規模將達到 61.2 億美元。本研究報告深入分析了當前的市場動態，並分析了未來的市場成長。

腫瘤分子診斷是一種先進的工具，可以解讀癌症相關的基因和分子變異，從而指導精準的臨床決策。隨著精準腫瘤學日益受到關注，腫瘤分子診斷市場正在不斷擴張。精準腫瘤學利用分子層面的洞察，根據個別腫瘤特徵客製化治療策略。這一趨勢反映了癌症治療領域更廣泛的變化：從仿製藥轉向標靶治療，以提高療效並最大限度地減少副作用。對此類個人化解決方案日益增長的需求，正在推動持續的技術創新，並將分子診斷融入標準的腫瘤學工作流程中。

液體活檢等非侵入性診斷技術日益普及，無需手術即可提供即時監測和早期檢測，進一步拓展了成長機會。這些技術進步使得動態評估疾病進展和治療反應成為可能，拓展了分子診斷的臨床應用。隨著醫療保健提供者尋求透過微創、高精度的診斷來改善患者預後，這些技術的開發和應用預計將繼續成為腫瘤診斷領域的前沿。

基於腫瘤的分子診斷市場：分析概述

按產品劃分，試劑細分市場是各種分子診斷和檢測技術（例如PCR、定序和雜交）必不可少的組成部分，其收入佔有率高達58.61%，佔市場領先地位。

按技術劃分，定序技術能夠提供對癌症基因組的詳細、高解析度洞察，預計將成為成長最快的細分市場。

得益於先進的醫療基礎設施、強大的研究生態系統以及創新診斷技術的早期應用，北美在腫瘤分子診斷市場佔主導地位，2024 年佔全球市場佔有率的 44.69%。

預計在預測期內，亞太市場將成長最快，這得益於支持性法規、高診斷​​標準以及對個人化癌症治療日益增長的需求。

全球腫瘤分子診斷市場的領導公司包括 Artivion, Inc.、Aroa Oncology Based Molecular Diagnostics、B. Braun SE、Baxter、BD、INTEGRA LIFESCIENCES、Johnson & Johnson Services, Inc.、Medtronic、Pfizer Inc.、Sanofi 和 Stryker。

目錄

第1章 簡介

第2章 摘要整理

第3章 分析方法

第4章 全球腫瘤分子診斷藥市場洞察

  • 市場概述
  • 腫瘤分子診斷藥的市場動態
    • 促進因素和機會
      • 全球癌症發生率和盛行率上升
      • 分子腫瘤檢測技術的進步
    • 限制因素與課題
      • 高昂的研發與營運成本
    • 公眾輿論與隱私先例
  • PESTEL 分析
  • 腫瘤分子診斷市場趨勢
  • 價值鏈分析

第5章 全球腫瘤分子診斷藥市場:各類型

  • 關鍵分析結果
  • 簡介
  • 乳癌
  • 攝護腺癌
  • 大腸直腸癌
  • 子宮頸癌
  • 肝癌
  • 肺癌
  • 血液癌
  • 腎癌
  • 其他

第6章 全球腫瘤分子診斷藥市場:各產品

  • 主要的分析結果
  • 簡介
  • 設備
  • 試劑
  • 其他

第7章 全球腫瘤分子診斷藥市場:各技術

  • 主要的分析結果
  • 簡介
  • PCR
  • 原位 雜合反應
  • INAAT
  • 晶片·微陣列
  • 質譜分析
  • 定序
  • TMA
  • 其他

第8章 全球腫瘤分子診斷藥市場:各地區

  • 主要的分析結果
  • 簡介
    • 腫瘤分子診斷藥市場分析:各地區 (2020～2034年)
  • 北美
    • 北美:各類型(2020～2034年)
    • 北美:各產品(2020～2034年)
    • 北美:各技術(2020～2034年)
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲:各類型(2020～2034年)
    • 歐洲:各產品(2020～2034年)
    • 歐洲:各技術(2020～2034年)
    • 英國
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 荷蘭
    • 俄羅斯
    • 其他歐洲
  • 亞太地區
    • 亞太地區:各類型(2020～2034年)
    • 亞太地區:各產品(2020～2034年)
    • 亞太地區:各技術(2020～2034年)
    • 中國
    • 印度
    • 馬來西亞
    • 日本
    • 印尼
    • 韓國
    • 澳洲
    • 其他亞太地區
  • 中東·非洲
    • 中東·非洲:各類型(2020～2034年)
    • 中東·非洲:各產品(2020～2034年)
    • 中東·非洲:各技術(2020～2034年)
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 南非
    • 其他中東·非洲
  • 南美
    • 南美:各類型(2020～2034年)
    • 南美:各產品(2020～2034年)
    • 南美:各技術(2020～2034年)
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他南美國家

第9章 競爭情形

  • 事業擴大·企業收購的分析
    • 事業擴大
    • 企業收購
  • 聯盟/合作/協定/公開

第10章 企業簡介

  • Abbott
  • Bayer AG
  • BD
  • Cepheid
  • Agilent Technologies, Inc.
  • Danaher
  • Hologic, Inc.
  • Qiagen
  • F. Hoffmann-La Roche Ltd.
  • Siemens
  • Sysmex
Product Code: PM6200

The oncology-based molecular diagnostics market size is expected to reach USD 6.12 billion by 2034, according to a new study by Polaris Market Research. The report "Oncology Based Molecular Diagnostics Market Share, Size, Trends, Industry Analysis Report By Product (Instruments, Reagents, Others), By Type, By Technology, By Region; Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Oncology-based molecular diagnostics are advanced tools that decode cancer-related genetic and molecular alterations to guide precise clinical decision-making. The oncology-based molecular diagnostics market is expanding due to the growing focus on precision oncology, where molecular insights are increasingly being used to tailor treatment strategies based on individual tumor profiles. This trend reflects a broader transformation in cancer care, moving from generalized therapies to targeted approaches that improve efficacy and minimize adverse effects. The growing demand for such personalized solutions is driving continuous innovation and integration of molecular diagnostics into standard oncology workflows.

The increasing adoption of noninvasive diagnostic techniques, such as liquid biopsy, which offer real-time monitoring and early detection without the need for surgical procedures, further contributes to the growth opportunities. These advancements are expanding the clinical utility of molecular diagnostics by enabling dynamic assessment of disease progression and treatment response. The development and utilization of such technologies are expected to remain at the forefront of the oncology diagnostics landscape as healthcare providers seek to enhance patient outcomes through minimally invasive and highly accurate diagnostics.

Oncology Based Molecular Diagnostics Market Report Highlights

In terms of product, the reagents segment led the market with 58.61% revenue share, as they are essential for various molecular diagnostic tests such as PCR, sequencing, and hybridization.

Based on technology, the sequencing segment is projected to grow the fastest due to its ability to deliver detailed, high-resolution cancer genomic insights.

North America dominated the oncology molecular diagnostics market with a 44.69% global share in 2024, supported by advanced healthcare infrastructure, a robust research ecosystem, and early adoption of innovative diagnostic technologies.

Asia Pacific market is expected to grow the fastest during the forecast period, fueled by supportive regulations, high diagnostic standards, and rising demand for personalized cancer care.

A few global key players in the oncology based molecular diagnostics market include Artivion, Inc.; Aroa Oncology Based Molecular Diagnostics; B. Braun SE; Baxter; BD; INTEGRA LIFESCIENCES; Johnson & Johnson Services, Inc.; Medtronic; Pfizer Inc.; Sanofi; and Stryker.

Polaris Market Research has segmented the oncology based molecular diagnostics market report on the basis of type, product, technology, and region:

By Type Outlook (Revenue, USD Billion, 2020-2034)

Breast Cancer

Prostate Cancer

Colorectal Cancer

Cervical Cancer

Liver Cancer

Lung Cancer

Blood Cancer

Kidney Cancer

Others

By Product Outlook (Revenue, USD Billion, 2020-2034)

Instruments

Reagents

Others

By Technology Outlook (Revenue, USD Billion, 2020-2034)

PCR

In situ hybridization

INAAT

Chips and microarrays

Mass spectrometry

Sequencing

TMA

Others

By Regional Outlook (Revenue, USD Billion, 2020-2034)

North America

U.S.

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Rest of Europe

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Vietnam

Australia

Rest of Asia Pacific

Latin America

Argentina

Brazil

Mexico

Rest of Latin America

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Rest of Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Oncology Based Molecular Diagnostics Market Insights

  • 4.1. Oncology Based Molecular Diagnostics Market - Market Snapshot
  • 4.2. Oncology Based Molecular Diagnostics Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising Incidence and Prevalence of Cancer Globally
      • 4.2.1.2. Rising Advancement in Molecular Oncology Tests Technology
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High R&D and operational costs
    • 4.2.3. Public opinion and privacy legal precedents
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Oncology Based Molecular Diagnostics Market Trends
  • 4.6. Value Chain Analysis

5. Global Oncology Based Molecular Diagnostics Market, by Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
  • 5.3. Breast Cancer
    • 5.3.1. Global Oncology Based Molecular Diagnostics Market, by Breast Cancer, by Region, 2020-2034 (USD Billion)
  • 5.4. Prostate Cancer
    • 5.4.1. Global Oncology Based Molecular Diagnostics Market, by Prostate Cancer, by Region, 2020-2034 (USD Billion)
  • 5.5. Colorectal Cancer
    • 5.5.1. Global Oncology Based Molecular Diagnostics Market, by Colorectal Cancer, by Region, 2020-2034 (USD Billion)
  • 5.6. Cervical Cancer
    • 5.6.1. Global Oncology Based Molecular Diagnostics Market, by Cervical Cancer, by Region, 2020-2034 (USD Billion)
  • 5.7. Liver Cancer
    • 5.7.1. Global Oncology Based Molecular Diagnostics Market, by Liver Cancer, by Region, 2020-2034 (USD Billion)
  • 5.8. Lung Cancer
    • 5.8.1. Global Oncology Based Molecular Diagnostics Market, by Lung Cancer, by Region, 2020-2034 (USD Billion)
  • 5.9. Blood Cancer
    • 5.9.1. Global Oncology Based Molecular Diagnostics Market, by Blood Cancer, by Region, 2020-2034 (USD Billion)
  • 5.10. Kidney Cancer
    • 5.10.1. Global Oncology Based Molecular Diagnostics Market, by Kidney Cancer, by Region, 2020-2034 (USD Billion)
  • 5.11. Others
    • 5.11.1. Global Oncology Based Molecular Diagnostics Market, by Others, by Region, 2020-2034 (USD Billion)

6. Global Oncology Based Molecular Diagnostics Market, by Product

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • 6.3. Instruments
    • 6.3.1. Global Oncology Based Molecular Diagnostics Market, by Instruments, by Region, 2020-2034 (USD Billion)
  • 6.4. Reagents
    • 6.4.1. Global Oncology Based Molecular Diagnostics Market, by Reagents, by Region, 2020-2034 (USD Billion)
  • 6.5. Others
    • 6.5.1. Global Oncology Based Molecular Diagnostics Market, by Others, by Region, 2020-2034 (USD Billion)

7. Global Oncology Based Molecular Diagnostics Market, by Technology

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • 7.3. PCR
    • 7.3.1. Global Oncology Based Molecular Diagnostics Market, by PCR, by Region, 2020-2034 (USD Billion)
  • 7.4. In situ hybridization
    • 7.4.1. Global Oncology Based Molecular Diagnostics Market, by In situ hybridization, by Region, 2020-2034 (USD Billion)
  • 7.5. INAAT
    • 7.5.1. Global Oncology Based Molecular Diagnostics Market, by INAAT, by Region, 2020-2034 (USD Billion)
  • 7.6. Chips and microarrays
    • 7.6.1. Global Oncology Based Molecular Diagnostics Market, by Chips and microarrays, by Region, 2020-2034 (USD Billion)
  • 7.7. Mass spectrometry
    • 7.7.1. Global Oncology Based Molecular Diagnostics Market, by Mass spectrometry, by Region, 2020-2034 (USD Billion)
  • 7.8. Sequencing
    • 7.8.1. Global Oncology Based Molecular Diagnostics Market, by Sequencing, by Region, 2020-2034 (USD Billion)
  • 7.9. TMA
    • 7.9.1. Global Oncology Based Molecular Diagnostics Market, by TMA, by Region, 2020-2034 (USD Billion)
  • 7.10. Others
    • 7.10.1. Global Oncology Based Molecular Diagnostics Market, by Others, by Region, 2020-2034 (USD Billion)

8. Global Oncology Based Molecular Diagnostics Market, by Geography

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Oncology Based Molecular Diagnostics Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 8.3. Oncology Based Molecular Diagnostics Market - North America
    • 8.3.1. North America: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
    • 8.3.2. North America: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
    • 8.3.3. North America: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
    • 8.3.4. Oncology Based Molecular Diagnostics Market - US
      • 8.3.4.1. US: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
      • 8.3.4.2. US: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.3.4.3. US: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
    • 8.3.5. Oncology Based Molecular Diagnostics Market - Canada
      • 8.3.5.1. Canada: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
      • 8.3.5.2. Canada: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.3.5.3. Canada: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • 8.4. Oncology Based Molecular Diagnostics Market - Europe
    • 8.4.1. Europe: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
    • 8.4.2. Europe: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
    • 8.4.3. Europe: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
    • 8.4.4. Oncology Based Molecular Diagnostics Market - UK
      • 8.4.4.1. UK: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
      • 8.4.4.2. UK: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.4.4.3. UK: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
    • 8.4.5. Oncology Based Molecular Diagnostics Market - France
      • 8.4.5.1. France: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
      • 8.4.5.2. France: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.4.5.3. France: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
    • 8.4.6. Oncology Based Molecular Diagnostics Market - Germany
      • 8.4.6.1. Germany: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
      • 8.4.6.2. Germany: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.4.6.3. Germany: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
    • 8.4.7. Oncology Based Molecular Diagnostics Market - Italy
      • 8.4.7.1. Italy: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
      • 8.4.7.2. Italy: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.4.7.3. Italy: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
    • 8.4.8. Oncology Based Molecular Diagnostics Market - Spain
      • 8.4.8.1. Spain: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
      • 8.4.8.2. Spain: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.4.8.3. Spain: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
    • 8.4.9. Oncology Based Molecular Diagnostics Market - Netherlands
      • 8.4.9.1. Netherlands: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
      • 8.4.9.2. Netherlands: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.4.9.3. Netherlands: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
    • 8.4.10. Oncology Based Molecular Diagnostics Market - Russia
      • 8.4.10.1. Russia: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
      • 8.4.10.2. Russia: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.4.10.3. Russia: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
    • 8.4.11. Oncology Based Molecular Diagnostics Market - Rest of Europe
      • 8.4.11.1. Rest of Europe: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
      • 8.4.11.2. Rest of Europe: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.4.11.3. Rest of Europe: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • 8.5. Oncology Based Molecular Diagnostics Market - Asia Pacific
    • 8.5.1. Asia Pacific: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
    • 8.5.2. Asia Pacific: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
    • 8.5.3. Asia Pacific: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
    • 8.5.4. Oncology Based Molecular Diagnostics Market - China
      • 8.5.4.1. China: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
      • 8.5.4.2. China: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.5.4.3. China: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
    • 8.5.5. Oncology Based Molecular Diagnostics Market - India
      • 8.5.5.1. India: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
      • 8.5.5.2. India: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.5.5.3. India: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
    • 8.5.6. Oncology Based Molecular Diagnostics Market - Malaysia
      • 8.5.6.1. Malaysia: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
      • 8.5.6.2. Malaysia: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.5.6.3. Malaysia: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
    • 8.5.7. Oncology Based Molecular Diagnostics Market - Japan
      • 8.5.7.1. Japan: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
      • 8.5.7.2. Japan: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.5.7.3. Japan: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
    • 8.5.8. Oncology Based Molecular Diagnostics Market - Indonesia
      • 8.5.8.1. Indonesia: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
      • 8.5.8.2. Indonesia: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.5.8.3. Indonesia: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
    • 8.5.9. Oncology Based Molecular Diagnostics Market - South Korea
      • 8.5.9.1. South Korea: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
      • 8.5.9.2. South Korea: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.5.9.3. South Korea: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
    • 8.5.10. Oncology Based Molecular Diagnostics Market - Australia
      • 8.5.10.1. Australia: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
      • 8.5.10.2. Australia: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.5.10.3. Australia: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
    • 8.5.11. Oncology Based Molecular Diagnostics Market - Rest of Asia Pacific
      • 8.5.11.1. Rest of Asia Pacific: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
      • 8.5.11.2. Rest of Asia Pacific: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.5.11.3. Rest of Asia Pacific: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • 8.6. Oncology Based Molecular Diagnostics Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
    • 8.6.2. Middle East & Africa: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
    • 8.6.3. Middle East & Africa: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
    • 8.6.4. Oncology Based Molecular Diagnostics Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
      • 8.6.4.2. Saudi Arabia: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
    • 8.6.5. Oncology Based Molecular Diagnostics Market - UAE
      • 8.6.5.1. UAE: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
      • 8.6.5.2. UAE: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.6.5.3. UAE: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
    • 8.6.6. Oncology Based Molecular Diagnostics Market - Israel
      • 8.6.6.1. Israel: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
      • 8.6.6.2. Israel: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.6.6.3. Israel: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
    • 8.6.7. Oncology Based Molecular Diagnostics Market - South Africa
      • 8.6.7.1. South Africa: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
      • 8.6.7.2. South Africa: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.6.7.3. South Africa: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
    • 8.6.8. Oncology Based Molecular Diagnostics Market - Rest of Middle East & Africa
      • 8.6.8.1. Rest of Middle East & Africa: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
      • 8.6.8.2. Rest of Middle East & Africa: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.6.8.3. Rest of Middle East & Africa: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • 8.7. Oncology Based Molecular Diagnostics Market - Latin America
    • 8.7.1. Latin America: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
    • 8.7.2. Latin America: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
    • 8.7.3. Latin America: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
    • 8.7.4. Oncology Based Molecular Diagnostics Market - Mexico
      • 8.7.4.1. Mexico: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
      • 8.7.4.2. Mexico: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.7.4.3. Mexico: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
    • 8.7.5. Oncology Based Molecular Diagnostics Market - Brazil
      • 8.7.5.1. Brazil: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
      • 8.7.5.2. Brazil: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.7.5.3. Brazil: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
    • 8.7.6. Oncology Based Molecular Diagnostics Market - Argentina
      • 8.7.6.1. Argentina: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
      • 8.7.6.2. Argentina: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.7.6.3. Argentina: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
    • 8.7.7. Oncology Based Molecular Diagnostics Market - Rest of Latin America
      • 8.7.7.1. Rest of Latin America: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
      • 8.7.7.2. Rest of Latin America: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
      • 8.7.7.3. Rest of Latin America: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Abbott
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Bayer AG
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. BD
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Cepheid
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Agilent Technologies, Inc.
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Danaher
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Hologic, Inc.
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Qiagen
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. F. Hoffmann-La Roche Ltd.
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Siemens
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Sysmex
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development

List of Tables:

  • Table 1 Global Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
  • Table 2 Global Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 3 Global Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 4 North America: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
  • Table 5 North America: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 6 North America: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 7 US: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
  • Table 8 US: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 9 US: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 10 Canada: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
  • Table 11 Canada: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 12 Canada: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 13 Europe: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
  • Table 14 Europe: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 15 Europe: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 16 UK: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
  • Table 17 UK: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 18 UK: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 19 France: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
  • Table 20 France: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 21 France: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 22 Germany: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
  • Table 23 Germany: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 24 Germany: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 25 Italy: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
  • Table 26 Italy: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 27 Italy: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 28 Spain: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
  • Table 29 Spain: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 30 Spain: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 31 Netherlands: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
  • Table 32 Netherlands: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 33 Netherlands: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 34 Russia: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
  • Table 35 Russia: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 36 Russia: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 37 Rest of Europe: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
  • Table 38 Rest of Europe: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 39 Rest of Europe: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 40 Asia Pacific: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
  • Table 41 Asia Pacific: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 42 Asia Pacific: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 43 China: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
  • Table 44 China: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 45 China: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 46 India: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
  • Table 47 India: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 48 India: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 49 Malaysia: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
  • Table 50 Malaysia: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 51 Malaysia: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 52 Japan: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
  • Table 53 Japan: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 54 Japan: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 55 Indonesia: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
  • Table 56 Indonesia: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 57 Indonesia: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 58 South Korea: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
  • Table 59 South Korea: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 60 South Korea: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 61 Australia: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
  • Table 62 Australia: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 63 Australia: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 64 Rest of Asia Pacific: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
  • Table 65 Rest of Asia Pacific: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 66 Rest of Asia Pacific: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 67 Middle East & Africa: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
  • Table 68 Middle East & Africa: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 69 Middle East & Africa: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 70 Saudi Arabia: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
  • Table 71 Saudi Arabia: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 72 Saudi Arabia: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 73 UAE: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
  • Table 74 UAE: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 75 UAE: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 76 Israel: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
  • Table 77 Israel: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 78 Israel: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 79 South Africa: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
  • Table 80 South Africa: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 81 South Africa: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 82 Rest of Middle East & Africa: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
  • Table 83 Rest of Middle East & Africa: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 84 Rest of Middle East & Africa: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 85 Latin America: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
  • Table 86 Latin America: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 87 Latin America: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 88 Mexico: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
  • Table 89 Mexico: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 90 Mexico: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 91 Brazil: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
  • Table 92 Brazil: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 93 Brazil: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 94 Argentina: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
  • Table 95 Argentina: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 96 Argentina: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)
  • Table 97 Rest of Latin America: Oncology Based Molecular Diagnostics Market, by Type, 2020-2034 (USD Billion)
  • Table 98 Rest of Latin America: Oncology Based Molecular Diagnostics Market, by Product, 2020-2034 (USD Billion)
  • Table 99 Rest of Latin America: Oncology Based Molecular Diagnostics Market, by Technology, 2020-2034 (USD Billion)

List of Figures:

  • Figure 1. Global Oncology Based Molecular Diagnostics Market, 2020-2034 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Type
  • Figure 7. Global Oncology Based Molecular Diagnostics Market, by Type, 2024 & 2034 (USD Billion)
  • Figure 8. Market by Product
  • Figure 9. Global Oncology Based Molecular Diagnostics Market, by Product, 2024 & 2034 (USD Billion)
  • Figure 10. Market by Technology
  • Figure 11. Global Oncology Based Molecular Diagnostics Market, by Technology, 2024 & 2034 (USD Billion)